Eleven U of T researchers have been awarded a grand total of $933,800 from the university’s own research funding source, the Connaught Fund. Professor Radhakrishnan Mahadevan from BioZone has been funded for his project titled, “Production of bio-based 1,3-butanediol.”
Founded in 1972, the Connaught Fund was created from the sale of the Connaught Laboratories. The labs mass-produced insulin, the Nobel Prize-winning discovery of U of T’s Frederick Banting, Charles Best, John Macleod and Charles Collip. The university has stewarded the fund in the years since, awarding more than $130 million to U of T researchers.
Today, the fund invests approximately $4 million annually in emerging and established scholars from the full spectrum of research and scholarship throughout U of T.
“Thanks to the innovation of the U of T researchers who discovered insulin, the Connaught Fund continues to enable innovation to thrive today,” said Professor Vivek Goel, Vice President, Research and Innovation. “Each of the projects being funded through these awards will, in its own way, move global society forward on fronts that affect us all every day. Thanks to all of our Connaught researchers for their excellent work.”
